Harvard Women's Health Watch

What to make of the new warning on bisphosphonates

There is growing evidence that long-term use of bisphosphonate drugs, commonly prescribed for osteoporosis, can increase the risk of fractures of the thighbone.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In